A Potential Peptide Therapeutic Derived from the Juxtamembrane Domain of the Epidermal Growth Factor Receptor

The epidermal growth factor receptor (EGFR) is involved in many cancers and EGFR has been heavily pursued as a drug target. Drugs targeting EGFR have shown promising clinical results for several cancer types. However, resistance to EGFR inhibitors often occurs, such as with KRAS mutant cancers, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Boran, Aislyn D. W., Seco, Joseph, Jayaraman, Vinodh, Jayaraman, Gomathi, Zhao, Shan, Reddy, Sushmitha, Chen, Yibang, Iyengar, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499488/
https://www.ncbi.nlm.nih.gov/pubmed/23166750
http://dx.doi.org/10.1371/journal.pone.0049702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499488/
https://www.ncbi.nlm.nih.gov/pubmed/23166750
http://dx.doi.org/10.1371/journal.pone.0049702

Ejemplares similares